/

Other

/

Takeda

Takeda

Takeda

Verified Nov 2026

Other

·

Japan flag

Osaka, Osaka Prefecture

·

Since 1781

Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.

Takeda

Verified Nov 2026

AT A GLANCE

Founded

1781

Headquarters

Japan flag

Osaka, Osaka Prefecture

Employees

10,000-50,000

Ownership

Takeda at a glance

Revenue

$10B+

Est. band

Employees

10,000-50,000

Founded

1781

Headquarters

Osaka, Osaka Prefecture

Import activity

78

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

78

Named foreign suppliers

20

Top origins

Italy · Germany · Netherlands · Spain

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Takeda.

What this tells a buyer

Takeda imported from at least six countries in recent years, with significant shipments from suppliers in Italy, Germany, Switzerland, and the Netherlands, indicating a diversified global supply chain for pharmaceutical ingredients and packaging.

The company operates across five core therapeutic areas including oncology and gastroenterology, with marketed brands such as Ninlaro, Entyvio, and Vyvanse, and maintains capabilities in vaccines and immunology.

As Japan's pharmaceutical company and in Asia, Takeda employs approximately 49,500 people globally and serves patients across the U.S., Japan, and Europe.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

245 years in operation (founded 1781).

78 US import shipments on record.

Overview

Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.

At a glance

Attribute

Detail

Founded

1781

Headquarters

Osaka, Osaka Prefecture

Employees

10,000-50,000

Revenue

$10B+ (estimated)

What Takeda makes

The company operates across five core therapeutic areas including oncology and gastroenterology, with marketed brands such as Ninlaro, Entyvio, and Vyvanse, and maintains capabilities in vaccines and immunology.

Products and capabilities described on the company's own site include Steel, LED (source: takeda.com).

Trade and customs footprint

Takeda imported from at least six countries in recent years, with significant shipments from suppliers in Italy, Germany, Switzerland, and the Netherlands, indicating a diversified global supply chain for pharmaceutical ingredients and packaging. US customs bill-of-lading records list 78 inbound shipments across 20 foreign suppliers, with top origins including Italy · Germany · Netherlands · Spain.

Latest developments

Facilities

Takeda is headquartered in Osaka, Osaka Prefecture. Public sources also reference these locations:

Company details

As Japan's pharmaceutical company and in Asia, Takeda employs approximately 49,500 people globally and serves patients across the U.S., Japan, and Europe. Takeda was founded in 1781, has an estimated 10,000-50,000 employees, and is headquartered in Osaka, Osaka Prefecture. On the LightSource stability read it is rated "Established & active": 245 years in operation (founded 1781). 78 US import shipments on record.

Frequently asked questions

What does Takeda do?

Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.

Where is Takeda headquartered?

Takeda is headquartered in Osaka, Osaka Prefecture.

When was Takeda founded?

Takeda was founded in 1781.

How big is Takeda?

Takeda has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).

Does Takeda import from overseas suppliers?

US customs bill-of-lading records show 78 inbound shipments for Takeda, with top origins including Italy · Germany · Netherlands · Spain.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Osaka, Osaka Prefecture (HQ)Headquarters · Osaka Prefecture, Japan
Osaka, Osaka Prefecture (HQ)Osaka, Osaka Prefecture, JapanHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.